Astellas Pharma Inc. (TYO: 4503)
Japan
· Delayed Price · Currency is JPY
1,750.50
-15.50 (-0.88%)
Oct 11, 2024, 3:15 PM JST
Astellas Pharma Employees
Astellas Pharma had 14,754 employees as of March 31, 2024. The number of employees increased by 270 or 1.86% compared to the previous year.
Employees
14,754
Change (1Y)
270
Growth (1Y)
1.86%
Revenue / Employee
115.35M JPY
Profits / Employee
1.46M JPY
Market Cap
3,138.87B
Employees Chart
Employees History
Astellas Pharma News
- 1 day ago - Astellas to Present VEOZA™ (fezolinetant) Data at IMS World Congress on Menopause - Benzinga
- 1 day ago - Astellas to Present VEOZA™ (fezolinetant) Data at IMS World Congress on Menopause - PRNewsWire
- 3 days ago - Astellas and AviadoBio Announce Exclusive Option and License Agreement for Gene Therapy AVB-101 Targeting Frontotemporal Dementia and Other Indications - PRNewsWire
- 8 days ago - eyma Bahi appointed as head of Astellas Pharma Turkey, Middle East and Africa area - Zawya
- 10 days ago - Singlera Genomics and Astellas Present Methylation-based Organ Toxicity Detection at 2024 JSOT Annual Meeting - Business Wire
- 21 days ago - Astellas Receives Approval from the European Commission for VYLOY™ (zolbetuximab) in Combination with Chemotherapy for Advanced Gastric and Gastroesophageal Junction Cancer - PRNewsWire
- 23 days ago - Astellas Announces FDA Listing of DIGITIVA™ for the Management of Heart Failure - PRNewsWire
- 4 weeks ago - Astellas Presents Scientific Progress in Advanced and Hard-to-Treat Cancers at ESMO 2024 - PRNewsWire